Abraham Avigdor
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 2
- Hematology top 10%
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 3
- Multiple Myeloma Research and Treatments 2
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 5
-
- Chronic Lymphocytic Leukemia Research 3
-
- CAR-T cell therapy research 2
-
- CNS Lymphoma Diagnosis and Treatment 2
- Co-authors
- Isaac Ben‐BassatArnon NaglerIzhar HardanTima DavidsonElinor GoshenItai LeviOrly GoiteinS. Tzila Zwas
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (1 paper)American Journal of Roentgenology (1 paper)
- Partner nations
- IsraelUnited States
In The Last Decade
Abraham Avigdor
14 papers receiving 416 citations
Peers
Comparison fields: 5 of 51
- Transplantation 30
- Hematology 111
- Pathology and Forensic Medicine 168
- Genetics 76
- Internal Medicine 26
Countries citing papers authored by Abraham Avigdor
This map shows the geographic impact of Abraham Avigdor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Avigdor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Avigdor more than expected).
Fields of papers citing papers by Abraham Avigdor
This network shows the impact of papers produced by Abraham Avigdor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Avigdor. The network helps show where Abraham Avigdor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abraham Avigdor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | IBRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): 2-YEAR FOLLOW-UP INCLUDING MRD FROM THE HELIOS STUDY | 2016 | 4 |
| 3 | 2015 | 23 | |
| 4 | 2011 | 47 | |
| 5 | 18F- FDG-PET/CT for the diagnosis of tumor thrombosis. | 2009 | 45 |
| 6 | 2008 | 22 | |
| 7 | 2007 | 133 | |
| 8 | 2005 | 1 | |
| 9 | 2004 | 38 | |
| 10 | 2003 | 18 | |
| 11 | 2002 | 32 | |
| 12 | 2001 | 37 | |
| 13 | 2000 | 20 | |
| 14 | [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. | 2000 | 1 |
About Abraham Avigdor
Abraham Avigdor is a scholar working on Transplantation, Hematology and Genetics, having authored 14 papers that have together received 426 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), CAR-T cell therapy research (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Multiple Myeloma Research and Treatments (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Transplantation (30 citations), Hematology (111 citations) and Pathology and Forensic Medicine (168 citations). Abraham Avigdor has collaborated with scholars based in Israel and United States. Frequent co-authors include Isaac Ben‐Bassat, Arnon Nagler, Izhar Hardan, Tima Davidson, Elinor Goshen, Itai Levi, Orly Goitein, S. Tzila Zwas, Avichai Shimoni and Moshe Yeshurun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and American Journal of Roentgenology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.